Keynote Financial Services LLC Trims Stock Position in Senseonics Holdings, Inc. Common Stock $SENS

Keynote Financial Services LLC cut its holdings in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) by 95.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,313 shares of the company’s stock after selling 201,037 shares during the quarter. Keynote Financial Services LLC’s holdings in Senseonics Holdings, Inc. Common Stock were worth $57,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. Jane Street Group LLC lifted its position in Senseonics Holdings, Inc. Common Stock by 148.9% during the fourth quarter. Jane Street Group LLC now owns 123,479 shares of the company’s stock worth $682,000 after buying an additional 73,874 shares during the period. GSK plc purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth about $60,000. Aristides Capital LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth about $139,000. Dimensional Fund Advisors LP purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth about $160,000. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Senseonics Holdings, Inc. Common Stock by 161.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 327,618 shares of the company’s stock worth $1,808,000 after purchasing an additional 202,106 shares during the period. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SENS. Weiss Ratings downgraded Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 28th. HC Wainwright cut their price objective on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, May 12th. Finally, Stifel Nicolaus cut their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Senseonics Holdings, Inc. Common Stock presently has an average rating of “Moderate Buy” and an average price target of $17.00.

Senseonics Holdings, Inc. Common Stock Price Performance

Senseonics Holdings, Inc. Common Stock stock opened at $7.18 on Friday. The stock has a market cap of $300.12 million, a P/E ratio of -3.59 and a beta of 1.04. The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05. Senseonics Holdings, Inc. Common Stock has a 12 month low of $4.79 and a 12 month high of $12.58. The stock has a 50-day moving average price of $6.50.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its earnings results on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing the consensus estimate of ($0.65) by ($0.06). The company had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. Research analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.38 EPS for the current year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In related news, Director Douglas A. Roeder bought 22,686 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average cost of $5.56 per share, for a total transaction of $126,134.16. Following the acquisition, the director owned 144,635 shares in the company, valued at $804,170.60. This represents a 18.60% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 4.70% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.